| Medium cut-off dialyzer versus eight hemodiafiltration dialyzers: comparison using a global removal score F Maduell, L Rodas, JJ Broseta, M Gomez, M Xipell, E Guillen, ... Blood Purification 48 (2), 167-174, 2019 | 93 | 2019 |
| Mucormycosis associated with COVID‐19 in two kidney transplant patients C Arana, RE Cuevas Ramirez, M Xipell, J Casals, A Moreno, S Herrera, ... Transplant Infectious Disease 23 (4), e13652, 2021 | 78 | 2021 |
| HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma B Gonzalez-Farre, D Martinez, M Lopez-Guerra, M Xipell, E Monclus, ... Modern Pathology 30 (5), 745-760, 2017 | 71 | 2017 |
| High‐permeability alternatives to current dialyzers performing both high‐flux hemodialysis and postdilution online hemodiafiltration F Maduell, L Rodas, JJ Broseta, M Gómez, M Xipell Font, A Molina, ... Artificial Organs 43 (10), 1014-1021, 2019 | 49 | 2019 |
| Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas … M Xipell, M Bodro, F Marco, RA Losno, C Cardozo, A Soriano International journal of antimicrobial agents 49 (2), 266-268, 2016 | 41 | 2016 |
| The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis MF Gomes, C Mardones, M Xipell, M Blasco, M Solé, G Espinosa, ... Journal of nephrology, 1-9, 2021 | 37 | 2021 |
| The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease A Molina-Andújar, P Robles, MT Cibeira, E Montagud-Marrahi, E Guillen, ... BMC nephrology 21, 1-7, 2020 | 31 | 2020 |
| Clinical experience with ceftolozane/tazobactam in patients with serious infections due to resistant Pseudomonas aeruginosa M Xipell, S Paredes, L Fresco, M Bodro, F Marco, JA Martínez, A Soriano Journal of Global Antimicrobial Resistance 13, 165-170, 2018 | 31 | 2018 |
| Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy M Xipell, I Victoria, V Hoffmann, J Villarreal, A Garcia-Herrera, O Reig, ... Oncoimmunology 7 (7), e1445952, 2018 | 23 | 2018 |
| Green inclusions in neutrophils: A critical finding that must be reported. R Vicente‐Steijn, A Tomé, F Maduell, M Xipell, P Castro, A Molina, ... International Journal of Laboratory Hematology 42 (3), 2020 | 22 | 2020 |
| Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end‐stage renal disease on hemodialysis … M Xipell, E Flores‐Umanzor, R Ojeda, M Arias, PL Cepas‐Guillén, ... Artificial Organs 44 (5), 513-521, 2020 | 22 | 2020 |
| Improved control of secondary hyperparathyroidism in hemodialysis patients switching from oral cinacalcet to intravenous etelcalcetide, especially in nonadherent patients M Xipell, E Montagud-Marrahi, MV Rubio, R Ojeda, M Arias-Guillén, ... Blood Purification 48 (2), 106-114, 2019 | 21 | 2019 |
| From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies M Xipell, GM Lledó, AC Egan, F Tamirou, CS Del Castillo, J Rovira, ... Autoimmunity Reviews, 103404, 2023 | 20 | 2023 |
| Successful Treatment of Three Severe Mdr or XDR Pseudomonas Aeruginosa iNfections with Ceftolozane/Tazobactam M Xipell, M Bodro, F Marco, JA Martínez, A Soriano Future microbiology 12 (14), 1323-1326, 2017 | 20 | 2017 |
| Optimization of dialysate bicarbonate in patients treated with online haemodiafiltration E Montagud-Marrahi, J Broseta, D Rodriguez-Espinosa, R Lidia, ... Clinical Kidney Journal 14 (3), 1004-1013, 2021 | 18 | 2021 |
| Assessing and counteracting fibrosis is a cornerstone of the treatment of CKD secondary to systemic and renal limited autoimmune disorders M de Cos, M Xipell, A García-Herrera, GM Lledo, E Guillen, M Blasco, ... Autoimmunity Reviews 21 (3), 103014, 2022 | 17 | 2022 |
| Evaluation of the influence of the surface membrane and blood flow in medium «cut-off»(MCO) dialyzers F Maduell, L Rodas, JJ Broseta, M Gómez, E Montagud-Marrahi, ... Nefrología (English Edition) 39 (6), 623-628, 2019 | 14 | 2019 |
| Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis F Caravaca-Fontán, K Stevens, M Padrón, A Huerta, M Montomoli, J Villa, ... Nephrology Dialysis Transplantation 39 (2), 328-340, 2024 | 13 | 2024 |
| Detection and significance of green inclusions in peripheral blood neutrophils and monocytes A Merino, A Molina, M Rodríguez‐García, R Vicente‐Steijn, A Tomé, ... International Journal of Laboratory Hematology 43 (2), e92-e94, 2021 | 10 | 2021 |
| Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment GM Lledó-Ibáñez, M Xipell, MF Gomes, M Solé, A Garcia-Herrera, ... Clinical Kidney Journal 15 (11), 2081-2088, 2022 | 9 | 2022 |
Luis F QuintanaMD, PhD, Servicio de Nefrología y Trasplante Renal. Hospital Clinic de BarcelonaVerified email at clinic.cat
